Faster Submissions. Smarter Launches.
Delays in submission or regulatory missteps can cost months, or more. At MethodSense, we help you move faster by streamlining documentation, preparing submission-ready content, and applying regulatory precision at every step. We understand the impact of missed timelines and use proven strategies to reduce risk, accelerate clearance, and support smarter go-to-market execution.
Regulatory Strategy & Pre-Sub Planning
Identifying the most efficient regulatory pathway early is critical to speeding your time to market. We work with your team to assess your product, claims, and target markets, and define the most strategic and achievable submission path.
- Define the fastest viable pathway: 510(k), De Novo, PMA, or MDR
- Align submission strategy with commercialization and funding timelines
- Optimize clinical and usability strategies to reduce rework
- Support Q-Sub preparation and agency engagement
Error-Free Submissions
The submission process shouldn’t be a bottleneck. With LuminLogic and expert guidance, we help you avoid common pitfalls by ensuring every element is complete, traceable, and ready for regulatory review.
- Use LuminLogic® to manage and track submission content
- Review documentation for structure, version control, and compliance
- Pre-validate content to reduce the risk of RTA or AI feedback
- Ensure alignment with FDA eSTAR and MDR formats
Automation & Templates
Efficiency isn’t just about speed. It’s about structure. LuminLogic accelerates progress through smart templates, automation, and document reuse features that reduce redundancy and streamline your workflows.
- Templates aligned with FDA and EU submission expectations
- Automated document tracking, routing, and version control
- Integration of risk, usability, and labeling into submission files
- Content reuse across global jurisdictions
- Reduce time-to-clearance by up to 40%
- Increase first-round submission success rates
- Minimize rework and reduce dependency on internal bandwidth
- Launch faster, with fewer compliance surprises